Moiseev, Ivan S <br/><br/>
Risk-adapted GVHD prophylaxis with post-transplantation cyclophosphamide in adults after related, unrelated, and haploidentical transplantations.  [electronic resource] 

 -  European journal of haematology  May 2018 
 - 395-402 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1600-0609 
<br/><br/><label>Standard No.: </label>10.1111/ejh.13030  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Cyclophosphamide--therapeutic use<br/>Female<br/>Graft Survival<br/>Graft vs Host Disease--diagnosis<br/>Hematopoietic Stem Cell Transplantation--adverse effects<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Postoperative Care<br/>Premedication<br/>Tissue Donors<br/>Transplantation Conditioning--adverse effects<br/>Transplantation, Haploidentical<br/>Transplantation, Homologous<br/>Treatment Outcome<br/>Young Adult